Regulation of Erythropoietin Gene Expression

Curtin, Peter T.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 5R29DK044956-02
• Application #: 3464670
• Study Section: Hematology Subcommittee 2 (HEM)
• Project Start: 1992-05-01
• Project End: 1993-07-31
• Budget Start: 1993-05-01
• Budget End: 1993-07-31
• Support Year: 2
• Fiscal Year: 1993

Institution

• Name: University of California San Francisco
• Type: Schools of Medicine
• DUNS #: 073133571
• City: San Francisco
• State: CA
• Country: United States
• Zip Code: 94143

Publications

Madan, A; Lin, C; Wang, Z et al. (2003) Autocrine stimulation by erythropoietin in transgenic mice results in erythroid proliferation without neoplastic transformation. Blood Cells Mol Dis 30:82-9

Kochling, J; Curtin, P T; Madan, A (1998) Regulation of human erythropoietin gene induction by upstream flanking sequences in transgenic mice. Br J Haematol 103:960-8

Madan, A; Lin, C; Hatch 2nd, S L et al. (1995) Regulated basal, inducible, and tissue-specific human erythropoietin gene expression in transgenic mice requires multiple cis DNA sequences. Blood 85:2735-41

Madan, A; Curtin, P T (1993) A 24-base-pair sequence 3' to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer. Proc Natl Acad Sci U S A 90:3928-32